Black, D. M., Thompson, A. R., Eastell, R. & Bouxsein, M. L. Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE. Lancet Diabetes Endocrinol. 12, 371–373 (2024).
Article PubMed CAS Google Scholar
Jensen, S. B. K. et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw. Open 7, e2416775 (2024).
Article PubMed PubMed Central Google Scholar
Angitia Incorporated. Angitia Biopharmaceuticals presents first-in-human data on AGA2118 for osteoporosis at ASBMR 2024. GlobeNewswire News Room https://www.globenewswire.com/en/news-release/2024/09/30/2955094/0/en/Angitia-Biopharmaceuticals-Presents-First-in-Human-Data-on-AGA2118-for-Osteoporosis-at-ASBMR-2024.html (2024).
Babey, M. E. et al. A maternal brain hormone that builds bone. Nature 632, 357–365 (2024).
Article PubMed PubMed Central CAS Google Scholar
Li, N. et al. Schnurri-3 inhibition rescues skeletal fragility and vascular skeletal stem cell niche pathology in the OIM model of osteogenesis imperfecta. Bone Res. 12, 46 (2024).
Article PubMed PubMed Central CAS Google Scholar
Collins, J. M. et al. YAP and TAZ couple osteoblast precursor mobilization to angiogenesis and mechanoregulation in murine bone development. Dev. Cell 59, 211–227.e5 (2024).
Article PubMed CAS Google Scholar
Bandyopadhyay, S. et al. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell 187, 3120–3140.e29 (2024).
Article PubMed CAS Google Scholar
Farr, J. N. et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23, 1072–1079 (2017).
Article PubMed PubMed Central CAS Google Scholar
Snyder, P. J. et al. Testosterone treatment and fractures in men with hypogonadism. N. Engl. J. Med. 390, 203–211 (2024).
Article PubMed CAS Google Scholar
Middelkoop, K. et al. Influence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids). J. Bone Miner. Res. 39, 211–221 (2024).
留言 (0)